Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/2007
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007139471A2 Method for chromatography
12/06/2007WO2007139028A1 Separating material and method for collecting cell or the like using the same
12/06/2007WO2007138198A2 Method for the extraction of one or several proteins present in milk
12/06/2007WO2007137867A1 Methods for the identification of zap-70 interacting molecules and for the purification of zap-70
12/06/2007WO2007137752A1 A method for generating metal chelating affinity ligands
12/06/2007WO2005072254A3 Modulation of sulfate permease for photosynthetic hydrogen production
12/06/2007WO2005044994A3 High temperature and alkaline stable catalase
12/06/2007WO2004074460A3 Nucleotide and protein sequences of coc genes and methods based thereon
12/06/2007WO2003023001A3 Novel proteins and nucleic acids encoding same
12/06/2007US20070281357 Fluidic methods for devices for parallel chemical reactions
12/06/2007US20070281338 comprises a sequence encoding glutaminyl cyclase (QC), a fusion protein tag upstream of the sequence encoding QC, and a linker region having at least one (His)x-tag between the sequence encoding QC and the fusion protein tag
12/06/2007US20070280957 Change of the Load State of Mhc Molecules
12/06/2007DE102006023822A1 Verfahren zur Abtrennung von Proteinen aus flüssigen Medien unter Verwendung thermisch modifizierter Tonmaterialien A process for separating proteins from liquid media using thermally-modified clay materials
12/06/2007CA2653926A1 Methods and reagents for detecting bioactive lipids
12/06/2007CA2653760A1 Methods for the identification of zap-70 interacting molecules and for the purification of zap-70
12/06/2007CA2652495A1 Method for the extraction of one or several proteins present in milk
12/05/2007EP1862802A1 Methods for the identification of ZAP-70 interacting molecules and for the purification of ZAP-70
12/05/2007EP1861497A1 Protein and its use in diagnosing alzheimer's disease
12/05/2007EP1861494A1 Recombinant protein comprising starch binding domain and use thereof
12/05/2007EP1861416A1 Obestatin and its uses
12/05/2007EP1403640B1 Peptide-immobilized baseboard and method of assaying target protein using the same
12/05/2007CN200985316Y Protein recovery ageing machine
12/05/2007CN101084435A Immobilized probes and methods of detecting conformationally altered prion proteins
12/05/2007CN101082045A Preparation method of apolipoprotein-J
12/05/2007CN101081865A Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof
12/05/2007CN101081864A A plurality of reconstructing antibiotic peptide and preparation method and application thereof
12/05/2007CN100352935C Method for producing dipeptide
12/05/2007CN100352839C Method for preparing insect protein with blood-fat reducing function
12/05/2007CN100352835C Corn albumen powder polypeptide, its separation method and uses
12/05/2007CN100352834C Polypeptide capable of suppressing weed seed germination and rootage, and separation method and uses
12/05/2007CN100352833C Polypeptide for suppressing weed seed germination and rootage, and separation method and uses
12/04/2007US7304181 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
12/04/2007US7304146 Detecting the phosphorylation activity of protein kinases using a substrate compound with hydrophobic moieties that integrate the compound into a micelle, non-proteinaceous fluorescent moieties (fluorescent dyes), and an enzyme recognition moiety
12/04/2007US7304140 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
12/04/2007US7304139 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
12/04/2007US7304135 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
12/04/2007US7304134 PRO9742 polypeptides
12/04/2007US7304128 High affinity and specificity, separation and immobilization of these structures for the fabrication of nano-devices
12/04/2007US7304016 Compositions for separating molecules
12/04/2007US7304015 Modified solid support is coupling with aminopropylsilane, amidation with nitrilotriacetic acid, metallization with metal salt; for use to separate metals or biomolecules such as polypeptides, nucleic acids, or endotoxins
12/04/2007US7303902 That are useful, e.g., as reagents or targets in assays applicable to treatment and diagnosis of protein kinase-associated or other 2150-associated disorders
12/04/2007US7303886 High throughput cell-based functional assays and using cells, e.g., HEK-293 cells that express a G protein such as G alpha 15, G alpha 16 or gustducin.
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them
11/2007
11/29/2007WO2007136463A2 Processes for improved disulfide bond formation in recombinant systems
11/29/2007WO2007136327A1 A method of producing igg
11/29/2007WO2007136159A1 Use of sphingosylphosphorylcholine antagonist for restoring the expression of antimicrobial peptides
11/29/2007WO2007109823A3 Peptide library
11/29/2007WO2007084977A3 Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency
11/29/2007WO2007061657A3 Interleukin-10 compositions for the treatment of adenocarcinomas
11/29/2007WO2005003294A3 Unnatural reactive amino acid genetic code additions
11/29/2007WO2004106361A3 Peptides for metal ion affinity chromatogrpahy
11/29/2007WO2004066958A3 Caspase-9:bir3 domain of xiap complexes and methods of use
11/29/2007US20070276131 Continuous Process for the Assembly of Macromolecular Substances and the Subsequent Capture and Isolation of Mamacromolecular Assembly and a System Suitable for the Process
11/29/2007US20070276128 Stabilized Proteins with Engineered Disulfide Bonds
11/29/2007US20070276127 Protein composition obtained from a muscle source
11/29/2007US20070276123 Amyloid Formation
11/29/2007US20070275916 Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)
11/29/2007US20070275880 Virally-Safe Factor VIII with a Low Content of Higher Multimers
11/29/2007US20070275481 Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis
11/29/2007US20070275439 Methods To Obtain Recombinant Proteins With Increased Sialylation From Cells That Express Adenovirus E1a Protein, And Proteins Obtained Thereby
11/29/2007US20070275368 Posh Associated Kinases And Related Methods
11/29/2007US20070275333 Method for Controlling the Treatment of a Crystal with a Liquid
11/29/2007US20070274918 Software system using a three-dimensional model of a crystal LINGO-1 polypeptide to design an agent that binds LINGO-1 and disables the Nogo; receptor complex; LINGO-1 signaling a negative regulator of myelin production; Lingo-1 antagonists; drug design; multiple sclerosis
11/29/2007US20070274885 Fractal-Forming Alkylketene Dimers For Integral Membrane Protein Crystal Growth
11/29/2007CA2652538A1 Fusion proteins, uses thereof and processes for producing same
11/28/2007EP1859277A2 Treating neurological disorders
11/28/2007EP1858928A2 Anti-m-csf antibody compositions having reduced levels of endotoxin
11/28/2007EP1858926A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/28/2007EP1858911A2 Macromolecules comprising a thioether cross-link
11/28/2007EP1601689B1 Purification process for bacterial cytolysin
11/28/2007EP1360490A4 Nucleic-acid programmable protein arrays
11/28/2007EP0991666B1 Alpha 1-antitrypsin preparation and method for the production thereof
11/28/2007EP0959682B1 Therapeutic applications of laminin and laminin-derived protein fragments
11/28/2007CN100351375C In vitro peptide expression library
11/28/2007CN100351269C Pseudomonas pseudoalcaligenes disinsection protein gene
11/28/2007CN100351267C Human urine anti-tumor (antibacterial) peptide, its preparation and use
11/28/2007CN100350980C Method for preparing 131I marker GM-CSF protein for treating leukemia
11/27/2007US7301067 Screening for peptides which when coated on stents and inserted into a human are useful for treating or preventing atherosclerosis or transplant arteriopathy or restenosis; identifying peptides that inhibit or cell proliferation or migration in vascular smooth muscle cells
11/27/2007US7301041 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules
11/27/2007US7301009 Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
11/27/2007US7301007 PRO4340 polypeptides
11/27/2007US7301006 Methods and materials for the synthesis of modified peptides
11/27/2007US7301004 Basic alkylation of vancomycin with O-(9-fluorenylmethyl)-N-decyl-acetaldehyde, acidification, reduction with an amine/borane complex, reaction with formaldehyde and an aminoalkylphosphonate, salt formation with hydrochloric acid
11/27/2007US7300918 Method of producing vaccines from protein signal oligopeptides
11/27/2007US7300782 Enhanced enzymatic polypeptide for use as component of cleaning compound; detergents; papermaking; textiles
11/27/2007US7300780 Nucleotide sequences coding misshapen/niks-related kinase proteins (MINK) for use as tools in identifying modulators for treatment of cell proliferative disorders; antitumor agents; antiproliferative agents
11/27/2007US7300778 Of given amino acid sequence; screening for modulator ligands; vectors, antisense transcripts or mutants
11/27/2007US7300753 immunoglobulin which binds phosphorylated ubiquitin fusion degradation protein 1 (UFD1) for use in diagnosis, prevention and treatment of cardiovascular and cell proliferative disorders
11/27/2007US7300663 Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers
11/27/2007US7300520 Contacting each of a plurality of reagents in separate compartments with compound, wherein each reagent has a predetermined concentration of two types of precipitating agents comprising salt and polyoxyethylene glycol; human immunodeficiency polypeptide viral polypeptides;
11/27/2007CA2301174C A method for inducing therapeutically-effective proteins
11/22/2007WO2007100358A3 Convergent synthesis of proteins by kinetically controlled ligation
11/22/2007WO2007056525A3 High affinity siglec ligands
11/22/2007WO2007027805A3 Method for generating anti-variable region monoclonal antibodies
11/22/2007WO2007018671A3 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
11/22/2007WO2006116410A3 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
11/22/2007WO2005012547A3 Multimeric oxidoreductases